Global Hepatitis C Drug Market Is Set for Rapid Growth, to Reach Around USD 27.63 Billion in 2021
Global demand for hepatitis C drug market was valued at USD 11.81 billion in 2015, to reach USD 27.63 billion in 2021 and is anticipated to grow at a CAGR of 17% by 2021
Global demand for hepatitis C drug market was valued at USD 11.81 billion in 2015, to reach USD 27.63 billion in 2021 and is anticipated to grow at a CAGR of 17% by 2021
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Published By: Zion Research<br />
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong> <strong>for</strong> (Hospitals, Private Labs, Physician Offices,<br />
Public Health Labs and Blood Banks) by Application - <strong>Global</strong> Industry<br />
Perspective, Comprehensive Analysis, Size, Share, <strong>Growth</strong>, Segment, Trends<br />
and Forecast, 2015 – <strong>2021</strong><br />
Joel John<br />
3422 SW 15 Street, Suit #8138,<br />
Deerfield Beach,<br />
Florida 33442, USA<br />
Tel: +1-386-310-3803<br />
Toll Free: 1-855-465-4651<br />
www.marketresearchs<strong>to</strong>re.com<br />
sales@marketresearchs<strong>to</strong>re.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
The report covers <strong>for</strong>ecast and analysis <strong>for</strong> the market on a global and regional level. The study provides<br />
his<strong>to</strong>ric data of hepatitis C drug market 2015 along with a <strong>for</strong>ecast from 2016 <strong>to</strong> <strong>2021</strong> based on revenue<br />
(<strong>USD</strong> billion). The study <strong>in</strong>cludes drivers and restra<strong>in</strong>ts <strong>for</strong> the hepatitis C drug market along with the<br />
impact they have on the demand over the <strong>for</strong>ecast period. Additionally, the report <strong>in</strong>cludes the study of<br />
opportunities available <strong>in</strong> the hepatitis C drug market on a global level.<br />
In order <strong>to</strong> give the users of this report a comprehensive view on the hepatitis C market, we have<br />
<strong>in</strong>cluded a detailed competitive scenario and type portfolio of key vendors. To understand the competitive<br />
landscape <strong>in</strong> the market, an analysis of Porter’s Five Forces model <strong>for</strong> the hepatitis C drug market has<br />
also been <strong>in</strong>cluded. The study encompasses a market attractiveness analysis, where<strong>in</strong> application<br />
segments are benchmarked based on their market size, growth rate and general attractiveness.<br />
Get sample report: http://www.marketresearchs<strong>to</strong>re.com/report/hepatitis-c-drug-marketz62423#RequestSample<br />
The study provides a decisive view on the hepatitis C drug market by segment<strong>in</strong>g the market based on<br />
applications. All the application segments have been analyzed based on present and future trends and<br />
the market is estimated from 2015 <strong>to</strong> <strong>2021</strong>. Hospitals, private labs, physician offices, public health labs,<br />
and blood banks are the key application of the hepatitis C drug market. The regional segmentation<br />
<strong>in</strong>cludes the current and <strong>for</strong>ecast demand <strong>for</strong> North America, Europe, Asia Pacific, Lat<strong>in</strong> America and<br />
Middle East & Africa with its further bifurcation <strong>in</strong><strong>to</strong> major countries <strong>in</strong>clud<strong>in</strong>g U.S., Canada, Germany,<br />
sales@marketresearchs<strong>to</strong>re.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
France, UK, Ch<strong>in</strong>a, Japan, India and Brazil. This segmentation <strong>in</strong>cludes demand <strong>for</strong> hepatitis C drug<br />
based on <strong>in</strong>dividual applications <strong>in</strong> all the regions and countries.<br />
Some of the key player <strong>in</strong> the hepatitis C drug market <strong>in</strong>cludes Merck & Co, Kenilworth, Roche, Basel<br />
GlaxoSmith, Gilead Sciences, AbbVie, Johnson & Johnson and Bris<strong>to</strong>l-Myers Squibb.<br />
The report segments the global hepatitis C drug market as<br />
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong>: Application Segment Analysis<br />
<br />
<br />
<br />
<br />
<br />
Hospitals<br />
Private labs<br />
Physician offices<br />
Public health labs<br />
Blood banks<br />
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong>: Regional Segment Analysis<br />
<br />
<br />
<br />
North America<br />
o U.S.<br />
Europe<br />
o Germany<br />
o UK<br />
o France<br />
Asia Pacific<br />
sales@marketresearchs<strong>to</strong>re.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
<br />
<br />
o Ch<strong>in</strong>a<br />
o Japan<br />
o India<br />
Lat<strong>in</strong> America<br />
o Brazil<br />
Middle East and Africa<br />
Get full report at http://www.marketresearchs<strong>to</strong>re.com/report/hepatitis-c-drugmarket-z62423<br />
<br />
<br />
Chapter 1. Preface<br />
o 1.1. Report description and scope<br />
o 1.2. Research scope<br />
o 1.3. Research methodology<br />
• 1.3.1. <strong>Market</strong> research process<br />
• 1.3.2. <strong>Market</strong> research methodology<br />
Chapter 2. Executive Summary<br />
o<br />
o<br />
2.1. <strong>Global</strong> hepatitis C drug market, 2015 - <strong>2021</strong>, (<strong>USD</strong> <strong>Billion</strong>)<br />
2.2. <strong>Hepatitis</strong> C drug: market snapshot<br />
sales@marketresearchs<strong>to</strong>re.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
Browse the full "<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong> <strong>for</strong> (Hospitals, Private Labs, Physician Offices, Public<br />
Health Labs and Blood Banks) by Application - <strong>Global</strong> Industry Perspective, Comprehensive<br />
Analysis, Size, Share, <strong>Growth</strong>, Segment, Trends and Forecast, 2015 – <strong>2021</strong>" report<br />
at http://www.marketresearchs<strong>to</strong>re.com/report/hepatitis-c-drug-market-z62423<br />
<br />
<br />
Chapter 3. <strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong>: Industry Analysis<br />
o<br />
o<br />
3.1. <strong>Hepatitis</strong> C drug : <strong>Market</strong> dynamics<br />
3.2. <strong>Market</strong> Drivers<br />
• 3.2.1. Increas<strong>in</strong>g <strong>in</strong>cidences of the disease<br />
• 3.2.2. New efficient therapies and comparatively smaller period of treatment<br />
• 3.2.3. Ris<strong>in</strong>g government fund<strong>in</strong>g<br />
o 3.3. Restra<strong>in</strong>ts<br />
• 3.3.1. Lack of awareness and <strong>in</strong><strong>for</strong>mation about HCV<br />
• 3.3.2. Treatment cost<br />
• 3.3.3. Threat related with regulation and development of drug<br />
o 3.4. Opportunity<br />
• 3.4.1. Advanc<strong>in</strong>g technologies and ongo<strong>in</strong>g research<br />
o 3.5. Porter’s Five Forces Analysis<br />
o 3.6. <strong>Market</strong> Attractiveness Analysis<br />
• 3.6.1. <strong>Market</strong> attractiveness analysis by application segment<br />
• 3.6.2. <strong>Market</strong> attractiveness analysis by regional segment<br />
Chapter 4. <strong>Global</strong> hepatitis C drug market: Competitive Landscape<br />
sales@marketresearchs<strong>to</strong>re.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
o<br />
4.1. Company <strong>Market</strong> Share Analysis<br />
• 4.1.1. <strong>Global</strong> hepatitis C drug market: company market share, 2015<br />
o 4.2. Strategic Development<br />
• 4.2.1. Acquisitions & Mergers<br />
• 4.2.2. New Product Launch<br />
• 4.2.3. Agreements, Partnerships, Collaborations and Jo<strong>in</strong>t Ventures<br />
• 4.2.4. Research and Development, Product and Regional Expansion<br />
o 4.3. Price Trend Analysis<br />
o 4.4. Product Portfolio<br />
o 4.5. Patent Analysis (2011-2016)<br />
• 4.5.1. Patent Trend<br />
• 4.5.2. Patent Share by company<br />
• 4.5.3. By Region<br />
Browse the full "<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong> <strong>for</strong> (Hospitals, Private Labs, Physician Offices, Public<br />
Health Labs and Blood Banks) by Application - <strong>Global</strong> Industry Perspective, Comprehensive<br />
Analysis, Size, Share, <strong>Growth</strong>, Segment, Trends and Forecast, 2015 – <strong>2021</strong>" report<br />
at http://www.marketresearchs<strong>to</strong>re.com/report/hepatitis-c-drug-market-z62423<br />
<br />
Chapter 5. <strong>Global</strong> hepatitis C market: Application Overview<br />
o 5.1. <strong>Global</strong> hepatitis C drug market share, by application, 2015 and <strong>2021</strong><br />
o 5.2. <strong>Global</strong> hepatitis C drug market <strong>for</strong> hospitals, 2015 - <strong>2021</strong>(<strong>USD</strong> <strong>Billion</strong>)<br />
o 5.3. <strong>Global</strong> hepatitis C drug market <strong>for</strong> private labs , 2015 - <strong>2021</strong> (<strong>USD</strong> <strong>Billion</strong>)<br />
o 5.4. <strong>Global</strong> hepatitis C drug market <strong>for</strong> physician offices, 2015 - <strong>2021</strong> (<strong>USD</strong> <strong>Billion</strong>)<br />
sales@marketresearchs<strong>to</strong>re.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
o<br />
o<br />
5.5. <strong>Global</strong> hepatitis C drug market <strong>for</strong> public health labs, 2015 - <strong>2021</strong> (<strong>USD</strong> <strong>Billion</strong>)<br />
5.6. <strong>Global</strong> hepatitis C drug market <strong>for</strong> blood banks, 2015 - <strong>2021</strong> (<strong>USD</strong> <strong>Billion</strong>)<br />
Browse the full "<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong> <strong>for</strong> (Hospitals, Private Labs, Physician Offices, Public<br />
Health Labs and Blood Banks) by Application - <strong>Global</strong> Industry Perspective, Comprehensive<br />
Analysis, Size, Share, <strong>Growth</strong>, Segment, Trends and Forecast, 2015 – <strong>2021</strong>" report<br />
at http://www.marketresearchs<strong>to</strong>re.com/report/hepatitis-c-drug-market-z62423<br />
<br />
Chapter 6. <strong>Global</strong> hepatitis C drug market: Regional Analysis<br />
o 6.1. <strong>Global</strong> hepatitis C drug market: Regional overview<br />
• 6.1.1. <strong>Global</strong> hepatitis C drug market share, by region, 2015 and <strong>2021</strong><br />
o 6.2. North America<br />
• 6.2.1. North America hepatitis C drug market revenue, by application, 2015 –<br />
<strong>2021</strong> (<strong>USD</strong> <strong>Billion</strong>)<br />
• 6.2.2. U.S.<br />
• 6.2.3. U.S. hepatitis C drug market revenue, by application, 2015 – <strong>2021</strong> (<strong>USD</strong><br />
<strong>Billion</strong>)<br />
o 6.3. Europe<br />
• 6.3.1. Europe hepatitis C drug market revenue, by application, 2015 – <strong>2021</strong> (<strong>USD</strong><br />
<strong>Billion</strong>)<br />
• 6.3.2. UK<br />
• 6.3.2.1. UK hepatitis C drug market revenue, by application, 2015 – <strong>2021</strong><br />
(<strong>USD</strong> <strong>Billion</strong>)<br />
• 6.3.3. France<br />
sales@marketresearchs<strong>to</strong>re.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
o<br />
o<br />
o<br />
• 6.3.3.1. France hepatitis C drug market revenue, by application, 2015 –<br />
<strong>2021</strong> (<strong>USD</strong> <strong>Billion</strong>)<br />
• 6.3.4. Germany<br />
• 6.3.4.1. Germany hepatitis C drug market revenue, by application, 2015 –<br />
<strong>2021</strong> (<strong>USD</strong> <strong>Billion</strong>)<br />
6.4. Asia Pacific<br />
• 6.4.1. Asia-Pacific hepatitis C drug market revenue, by application, 2015 – <strong>2021</strong><br />
(<strong>USD</strong> <strong>Billion</strong>)<br />
• 6.4.2. Ch<strong>in</strong>a<br />
• 6.4.2.1. Ch<strong>in</strong>a hepatitis C drug market revenue, by application, 2015 –<br />
<strong>2021</strong> (<strong>USD</strong> <strong>Billion</strong>)<br />
• 6.4.3. Japan<br />
• 6.4.3.1. Japan hepatitis C drug market revenue, by application, 2015 –<br />
<strong>2021</strong> (<strong>USD</strong> <strong>Billion</strong>)<br />
• 6.4.4. India<br />
• 6.4.4.1. India hepatitis C drug market revenue, by application, 2015 –<br />
<strong>2021</strong> (<strong>USD</strong> <strong>Billion</strong>)<br />
6.5. Lat<strong>in</strong> America<br />
• 6.5.1. Lat<strong>in</strong> America hepatitis C drug market revenue, by application, 2015 – <strong>2021</strong><br />
(<strong>USD</strong> <strong>Billion</strong>)<br />
• 6.5.2. Brazil<br />
• 6.5.2.1. Brazil hepatitis C drug market revenue, by application, 2015 –<br />
<strong>2021</strong> (<strong>USD</strong> <strong>Billion</strong>)<br />
6.6. Middle East & Africa<br />
sales@marketresearchs<strong>to</strong>re.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
<br />
• 6.6.1. Middle East & Africa hepatitis C drug market revenue, by application, 2015<br />
– <strong>2021</strong> (<strong>USD</strong> <strong>Billion</strong>)<br />
Chapter 7. Company Profiles<br />
o<br />
o<br />
7.1. Merck & Co<br />
• 7.1.1. Overview<br />
• 7.1.2. F<strong>in</strong>ancials<br />
• 7.1.3. Product portfolio<br />
• 7.1.4. Bus<strong>in</strong>ess strategy<br />
• 7.1.5. Recent developments<br />
7.2. Kenilworth<br />
• 7.2.1. Overview<br />
• 7.2.2. F<strong>in</strong>ancials<br />
• 7.2.3. Product portfolio<br />
• 7.2.4. Bus<strong>in</strong>ess strategy<br />
• 7.2.5. Recent developments<br />
Browse the full "<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong> <strong>for</strong> (Hospitals, Private Labs, Physician Offices, Public<br />
Health Labs and Blood Banks) by Application - <strong>Global</strong> Industry Perspective, Comprehensive<br />
Analysis, Size, Share, <strong>Growth</strong>, Segment, Trends and Forecast, 2015 – <strong>2021</strong>" report<br />
at http://www.marketresearchs<strong>to</strong>re.com/report/hepatitis-c-drug-market-z62423<br />
o<br />
7.3. Roche<br />
• 7.3.1. Overview<br />
• 7.3.2. F<strong>in</strong>ancials<br />
sales@marketresearchs<strong>to</strong>re.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
o<br />
o<br />
o<br />
o<br />
• 7.3.3. Product portfolio<br />
• 7.3.4. Bus<strong>in</strong>ess strategy<br />
• 7.3.5. Recent developments<br />
7.4. Basel Glaxosmith<br />
• 7.4.1. Overview<br />
• 7.4.2. F<strong>in</strong>ancials<br />
• 7.4.3. Product portfolio<br />
• 7.4.4. Bus<strong>in</strong>ess strategy<br />
• 7.4.5. Recent developments<br />
7.5. Gilead Sciences<br />
• 7.5.1. Overview<br />
• 7.5.2. F<strong>in</strong>ancials<br />
• 7.5.3. Product portfolio<br />
• 7.5.4. Bus<strong>in</strong>ess strategy<br />
• 7.5.5. Recent developments<br />
7.6. Abbvie<br />
• 7.6.1. Overview<br />
• 7.6.2. F<strong>in</strong>ancials<br />
• 7.6.3. Product portfolio<br />
• 7.6.4. Bus<strong>in</strong>ess strategy<br />
• 7.6.5. Recent developments<br />
7.7. Bris<strong>to</strong>l- Myers Squibb.d<br />
• 7.7.1. Overview<br />
• 7.7.2. F<strong>in</strong>ancials<br />
sales@marketresearchs<strong>to</strong>re.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
<br />
• 7.7.3. Product portfolio<br />
• 7.7.4. Bus<strong>in</strong>ess strategy<br />
• 7.7.5. Recent developments<br />
o 7.8. Johnson & Johnson<br />
• 7.8.1. Overview<br />
• 7.8.2. F<strong>in</strong>ancials<br />
• 7.8.3. Product portfolio<br />
• 7.8.4. Bus<strong>in</strong>ess strategy<br />
• 7.8.5. Recent Developments<br />
Chapter 8. Patents<br />
o 8.1. U.S. (US Patents)<br />
o 8.2. Europe (EP documents)<br />
o 8.3. Japan (Abstracts of Japan)<br />
o 8.4. <strong>Global</strong> (WIPO (PCT))<br />
sales@marketresearchs<strong>to</strong>re.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
Browse the full "<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong> <strong>for</strong> (Hospitals, Private Labs, Physician Offices, Public<br />
Health Labs and Blood Banks) by Application - <strong>Global</strong> Industry Perspective, Comprehensive<br />
Analysis, Size, Share, <strong>Growth</strong>, Segment, Trends and Forecast, 2015 – <strong>2021</strong>" report<br />
at http://www.marketresearchs<strong>to</strong>re.com/report/hepatitis-c-drug-market-z62423<br />
<strong>Market</strong> Research S<strong>to</strong>re<br />
Address: Suite #8138, 3422 SW 15 Street, Deerfield Beach, Florida 33442, USA<br />
Tel: +1-386-310-3803<br />
Tel: +1-855-465-4651 (US/CAN TOLL FREE)<br />
Email: sales@marketresearchs<strong>to</strong>re.com<br />
Web : http://www.marketresearchs<strong>to</strong>re.com<br />
sales@marketresearchs<strong>to</strong>re.com
Change language